Predicate |
Object |
contentType |
Journal Article|Research Support, Non-U.S. Gov't|Review |
endingPage |
378 |
issn |
1175-3277 1179-187X |
issueIdentifier |
6 |
pageRange |
369-378 |
publicationName |
American journal of cardiovascular drugs : drugs, devices, and other interventions |
startingPage |
369 |
bibliographicCitation |
Verdecchia P, Angeli F. Reversal of left ventricular hypertrophy: what have recent trials taught us? Am J Cardiovasc Drugs. 2004;4(6):369–78. doi: 10.2165/00129784-200404060-00005. PMID: 15554722. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c513e8b2fbbb45a73de147b2ebca62e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee965731b129db21cc2d001e7441e690 |
date |
200411 |
identifier |
https://doi.org/10.2165/00129784-200404060-00005 https://pubmed.ncbi.nlm.nih.gov/15554722 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31760 https://portal.issn.org/resource/ISSN/1179-187X https://portal.issn.org/resource/ISSN/1175-3277 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Reversal of left ventricular hypertrophy: what have recent trials taught us? |
discusses |
http://id.nlm.nih.gov/mesh/M0001456 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388962 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3702 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10017 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249 |